Scientists launch studies to address long term safety and effectiveness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Eyebrows raised over extended age range for cervical cancer vaccine
Experts inject reality into cervical cancer prevention schemes
Cervical cancer vaccine comes closer to market
Related external links
Rights and permissions
About this article
Cite this article
Keim, B. Controversy over cervical cancer vaccine spurs safety surveillance. Nat Med 13, 392–393 (2007). https://doi.org/10.1038/nm0407-392b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0407-392b